Next week our CEO Dolores Baksh, Ph.D. will be attending ISCT, International Society for Cell & Gene Therapy Annual Meeting in Paris.
We are excited to join the international Gene Therapy industry in this edition’s goal: Celebrating the Progress of Advanced Therapies and Building the Future Through Translations.
Dolores will be there hearing from the market and learning more about how TAAV can be the right partner for your rAAV manufacturing.
neDNA™, TAAV-manufactured enzymatic DNA offers an alternative to plasmid that intends to be safer producing higher and faster yields at lower costs.
Get to know more about neDNA™ here.
Looking forward to meeting you:
📅 May 31st to June 3rd 2023
📍 Paris, France
